SCHEMBL10751

SCHEMBL10751

CC(Oc1ccc(N)cc1)C(F)(F)F.CC(Oc1ccc([N+](=O)[O-])cc1)C(F)(F)F

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.53
KMT2A Q03164 7/20 0.48
PKM P14618 1/20 0.48
MEN1 O00255 5/20 0.45
MAPT P10636 3/20 0.45
ESR1 P03372 2/20 0.43
CYP19A1 P11511 2/20 0.43
ESR2 Q92731 2/20 0.43
NPC1 O15118 2/20 0.43
HTT P42858 1/20 0.43
RAB9A P51151 1/20 0.43
PDE7A Q13946 2/20 0.43
HSPB1 P04792 1/20 0.41
LMNA P02545 2/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA9 Q16790 2/20 0.41
HTR2A P28223 1/20 0.40
CA5A P35218 1/20 0.39
GAA P10253 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5630 0.92 MEN1 (0.48) ALDH1A1KMT2AMEN1MAPTNPC1
SCHEMBL11433 0.84 TDP1 (0.43) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL11238 0.84 TDP1 (0.43) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL10941 0.84 TDP1 (0.43) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL12818771 0.81 TDP1 (0.40) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL10498244 0.74 HSPB1 (0.49) ALDH1A1KMT2AMEN1MAPTNPC1
SCHEMBL8020422 0.74 ALDH1A1 (0.69) ALDH1A1KMT2APKMMEN1MAPT
SCHEMBL21633908 0.74 MEN1 (0.51) ALDH1A1KMT2AMEN1MAPTNPC1
SCHEMBL9320810 0.73 MEN1 (0.54) ALDH1A1KMT2AMEN1MAPTNPC1
SCHEMBL554299 0.73 ALDH1A1 (0.75) ALDH1A1KMT2APKMMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488493-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. Hoffmann-La Roche AG (CH) 2012-08-22 EP disclosed
WO-2011045292-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-04-21 WO disclosed